Concordantly, in a nested prospective biomarker study of the ENGAGE AF-TIMI 48 trial, including 8705 patients, elevated GDF-15 was independently associated with higher rates of stroke and major bleeding. The gene discussed is GDF15; the disease is stroke disorder.